Esrovan Ointment (Mupriocin)

Adult use

Apply a small amount to the infected area 2-3 times a day for 10 days. If necessary, dress or seal the applied area.

This medication should not be used by patients who are allergic or have had hypersensitivity reactions to this drug or any of its components, including polyethylene glycol. Patients with kidney function issues should avoid using this medication as the polyethylene glycol contained in this drug can be absorbed through wounds or damaged skin and excreted via the kidneys. It is safest for women who are pregnant, may become pregnant, or are breastfeeding to avoid using this medication. Long-term use of this medication on torn wounds or damaged skin should be approached with caution, as there is insufficient safety data regarding immune function suppression from animal studies. When using this medication, skin hypersensitivity reactions such as burning sensation, pain, itching, rash, or red spots may occur. If such symptoms appear, discontinue use immediately and consult a physician or pharmacist. Rarely, symptoms such as nausea, dry skin, pain, swelling, contact dermatitis, and increased exudate may occur, and very rarely systemic allergic reactions have been reported. If severe skin irritation or allergic symptoms occur while using this medication, clean the area thoroughly and consult a medical professional for appropriate treatment options. To prevent antibiotic resistance, this medication should only be used for the minimum duration necessary after confirming sensitivity to the infecting bacteria. With long-term use, caution is needed, as excessive growth of fungi or other microorganisms may occur. If symptoms do not improve after 3 to 5 days of use, it is essential to review treatment options with a physician or pharmacist. When applying this medication to the face, special care should be taken to avoid contact with the eyes. There are no known side effects that affect driving or operating machinery. When used in conjunction with other medications, the effectiveness of this drug may be diminished, so it is advisable to consult a specialist regarding any concurrently used medications. During pregnancy or breastfeeding, it is recommended not to use due to unconfirmed safety, and breastfeeding should be discontinued during the period of use. In case of overdose, toxicity is very low; however, the application area should be cleaned, and treatment tailored to the symptoms should be applied. This medication must be used only externally and should not be applied to mucous membranes such as the eyes or nose. Caution is necessary when using inside the nose, as pain or dryness may occur. It is not appropriate to use this medication on central venous catheter insertion sites. This medication should be stored in a safe place out of reach of children, and transferring it to other containers may cause a decline in quality or accidents, so caution is warranted. Unused medication after therapy should be disposed of appropriately.

Serious side effects

Systemic allergic reaction

Mild side effects

• Burning sensation
• pain
• discomfort
• itching
• rash
• erythema
• nausea
• dry skin
• tenderness
• contact dermatitis

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature.

Appearance

Esrovan Ointment (Mupriocin): A light white uniform ointment Esrovan Ointment (Mupriocin) (Tea Tree Scent): A light white uniform ointment with a distinctive fragrance

Package unit

Esrovan Ointment (Mupriocin) - 10 grams/tube [(AL)], Esrovan Ointment (Mupriocin) - 450 grams/bottle, Esrovan Ointment (Mupriocin) (Tea Tree Scent) - 5 grams/tube [(AL)], Esrovan Ointment (Mupriocin) (Tea Tree Scent) - 10 grams/tube, Esrovan Ointment (Mupriocin) (Tea Tree Scent) - 15 grams/tube